NHS National Framework Agreement for the supply of products for the management of Herediatary Angioedema
The value below is a framework or dynamic market ceiling: the maximum
that could be spent across all call-offs, not the value of a single contract.
Aggregate figures on this site exclude these to avoid double counting.
key details
| Value | £74,500,000 |
|---|---|
| Status | planned |
| Category (CPV) | 33141510 +2 more |
| Contract start | 1 Jul 2022 |
| Contract end | 31 Dec 2023 |
| Procedure | open |
| SME suitable | Yes |
| OCID | ocds-b5fd17-cb0ef35e-b7c8-44f7-a4ec-4875b1ff6f01 |
description
National Framework Agreement for the supply of products for the management of Hereditary Angioedema
Period of framework agreement: 1 July 2022 to 31 December 2023 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 30 months. Total maximum framework agreement including extension options will be no more than 48 months
notice history
1 notice published against this procurement.
| Published | Type | Regime | Notice |
|---|---|---|---|
| 3 Feb 2022 | Planning (planning) | · | 5f66a3d1-7bf9-4d01-bb13-5eaecea498da-507043 |
more from NHS ENGLAND
- Products for the treatment of Haemophilia A · £215,000,000 · 11 May 2023
- NHS Framework Agreement for the supply of products for the treatment of Haemophilia A · £215,000,000 · 26 Apr 2023
- NHS Framework Agreement for the Supply of Human Normal Immunoglobulin & Anti-D Immunoglobulin · £526,598,540 · 3 Feb 2023
- NHS Framework Agreement for the supply of Adult Influenza Vaccines - Secondary Care · £16,000,000 · 22 Jul 2022
- National Framework Agreement for the supply of products for the management of Hereditary Angioedema · £74,500,000 · 5 Jul 2022
- NHS National Framework Agreement for the supply of products for the management of Hereditary Angioedema · £74,500,000 · 5 Jul 2022
- NHA National Framework Agreement for the supply of products for the treatment of Bleeding Disorders including Haemophilia B · £250,000,000 · 5 Jul 2022
- NHS National Framework Agreement for the supply of products for the treatment of Haemophilia A · £214,000,000 · 22 Mar 2022
all contracts from this buyer →
similar contracts awarded
Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.
- NHS Blood and Transplant NGH · Northampton General Hospital NHS Trust
- NHS Blood and Transplant · Kettering General Hospital NHS Foundation Trust
- GB-London: UKRI-4607 FBS Specific Batch Upfront Purchase & Stock Reservation · UK Research and Innovation · £49,050
- Purchase of Contrast Injectors · Leeds Teaching Hospitals NHS Trust · £48,735
- GB-London: UKRI-4445 MRC LMS Biobank samples · UK Research & Innovation · £27,910
- CA14213 - Contract for the Supply of Blood Components, Reagents and Services · Partners Procurement Service (PPS)
- BloodTrack Tx System · ST HELENS & KNOWSLEY TEACHING HOSPITALS NHS TRUST · £32,306
- HRI 10 month Standing order for Human Albumin solution · Calderdale and Huddersfield Solutions · £14,250
source
Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.